BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 32325672)

  • 1. Population Pharmacokinetic Analysis of Tiropramide in Healthy Korean Subjects.
    Jeong SH; Jang JH; Cho HY; Lee YB
    Pharmaceutics; 2020 Apr; 12(4):. PubMed ID: 32325672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population Pharmacokinetics of
    Jang JH; Jeong SH; Cho HY; Lee YB
    Pharmaceutics; 2019 Oct; 11(10):. PubMed ID: 31614996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population Pharmacokinetic Analysis of Cefaclor in Healthy Korean Subjects.
    Jeong SH; Jang JH; Cho HY; Lee YB
    Pharmaceutics; 2021 May; 13(5):. PubMed ID: 34069627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetics of gabapentin in healthy Korean subjects with influence of genetic polymorphisms of ABCB1.
    Tran P; Yoo HD; Ngo L; Cho HY; Lee YB
    J Pharmacokinet Pharmacodyn; 2017 Dec; 44(6):567-579. PubMed ID: 29018999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population Pharmacokinetic Analysis of Valsartan in Healthy Chinese Subjects.
    Yang H; Gao R; Ji X; Wang Z; Qiu W
    Clin Pharmacol Drug Dev; 2023 Mar; 12(3):249-256. PubMed ID: 36285517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population Pharmacokinetic (Pop-PK) Analysis of Torsemide in Healthy Korean Males Considering CYP2C9 and OATP1B1 Genetic Polymorphisms.
    Jeong SH; Jang JH; Cho HY; Lee YB
    Pharmaceutics; 2022 Apr; 14(4):. PubMed ID: 35456605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A population pharmacokinetic model for individualised dosage regimens of vancomycin in Chinese neonates and young infants.
    Song L; He CY; Yin NG; Liu F; Jia YT; Liu Y
    Oncotarget; 2017 Dec; 8(62):105211-105221. PubMed ID: 29285245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetic analysis of rebamipide in healthy Korean subjects with the characterization of atypical complex absorption kinetics.
    Ngo L; Yoo HD; Tran P; Cho HY; Lee YB
    J Pharmacokinet Pharmacodyn; 2017 Aug; 44(4):291-303. PubMed ID: 28316019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetic modeling of flurbiprofen, the active metabolite of flurbiprofen axetil, in Chinese patients with postoperative pain.
    Zhang J; Zhang H; Zhao L; Gu J; Feng Y; An H
    J Pain Res; 2018; 11():3061-3070. PubMed ID: 30555252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetic analysis of transdermal granisetron in healthy Chinese and Caucasian volunteers.
    Li J; Hu P; Zhou L; Nagahama F; Chen R
    Front Pharmacol; 2023; 14():1154026. PubMed ID: 37435499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NONMEM population pharmacokinetic studies of cytosine arabinoside after high-dose and after loading bolus followed by continuous infusion of the drug in pediatric patients with leukemias.
    Periclou AP; Avramis VI
    Cancer Chemother Pharmacol; 1996; 39(1-2):42-50. PubMed ID: 8995498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Population Pharmacokinetic Study to Compare a Novel Empagliflozin L-Proline Formulation with Its Conventional Formulation in Healthy Subjects.
    Jiang X; Yu KS; Nam DH; Oh J
    Pharmaceuticals (Basel); 2024 Apr; 17(4):. PubMed ID: 38675482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of tiropramide after single doses in man.
    Arigoni R; Chisté R; Drovanti A; Makovec F; Senin P; Setnikar I
    Arzneimittelforschung; 1986 Apr; 36(4):738-44. PubMed ID: 3718598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetics of doxorubicin: establishment of a NONMEM model for adults and children older than 3 years.
    Kontny NE; Würthwein G; Joachim B; Boddy AV; Krischke M; Fuhr U; Thompson PA; Jörger M; Schellens JH; Hempel G
    Cancer Chemother Pharmacol; 2013 Mar; 71(3):749-63. PubMed ID: 23314734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experimental studies of urinary incontinence. Effect of tiropramide on the urinary stage and evacuation].
    Morita T; Ando M; Hirano S; Dokita S; Kondo S; Tsuchida S
    Nihon Hinyokika Gakkai Zasshi; 1992 Nov; 83(11):1835-40. PubMed ID: 1336080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research Progress of Population Pharmacokinetic of Metformin.
    Wang X; Tang J; Shen C; Wang X; Hu H; Xie H
    Biomed Res Int; 2022; 2022():4071111. PubMed ID: 36578804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative analysis of tiropramide in human plasma by gas chromatography coupled to mass spectrometry for application to a bioequivalence test.
    Jhee OH; Jeon YC; Choi HS; Lee MH; Om AS; Lee JW; Hong JW; Kim YS; Kang JC; Lee YS; Shaw LM; Kang JS
    Clin Chim Acta; 2006 Apr; 366(1-2):179-84. PubMed ID: 16352299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population pharmacokinetics of epinastine, a histamine H1 receptor antagonist, in adults and children.
    Sarashina A; Tatami S; Yamamura N; Tsuda Y; Igarashi T
    Br J Clin Pharmacol; 2005 Jan; 59(1):43-53. PubMed ID: 15606439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetics of an angiotensin II receptor antagonist, telmisartan, in healthy volunteers and hypertensive patients.
    Tatami S; Sarashina A; Yamamura N; Igarashi T; Tanigawara Y
    Drug Metab Pharmacokinet; 2003; 18(3):203-11. PubMed ID: 15618736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetics of tacrolimus in pediatric refractory nephrotic syndrome and a summary of other pediatric disease models.
    Wang D; Lu J; Li Q; Li Z
    Exp Ther Med; 2019 May; 17(5):4023-4031. PubMed ID: 31007740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.